Iranian Red Crescent Medical Journal

Published by: Kowsar

A Multicenter Study on Expressions of Vascular Endothelial Growth Factor, Matrix Metallopeptidase-9 and Tissue Inhibitor of Metalloproteinase-2 in Oral and Maxillofacial Squamous Cell Carcinoma

Min Li 1 , Zhiying Wang 1 , * , Yang Xing 2 , Jin Yu 3 , Luming Tian 4 , Dianming Zhang 5 and Zengxi Xin 3
Authors Information
1 Department of Oral Implantology, Second Affiliated Hospital of Liaoning Medical University, Jinzhou, China
2 Jinzhou City Oral Cavity Hospital, Jinzhou, China
3 Department of Prosthodontics, Second Affiliated Hospital of Liaoning Medical University, Jinzhou, China
4 Department of Oral and Maxillofacial Surgery, Second Affiliated Hospital of Liaoning Medical University, Jinzhou, China
5 Department of Stomatology, Hospital of Liaoning University of Technology, Jinzhou, China
Article information
  • Iranian Red Crescent Medical Journal: March 5, 2014, 16 (3); e13185
  • Published Online: March 5, 2014
  • Article Type: Research Article
  • Received: June 25, 2013
  • Revised: December 11, 2013
  • Accepted: January 29, 2014
  • DOI: 10.5812/ircmj.13185

To Cite: Li M, Wang Z, Xing Y, Yu J, Tian L, et al. A Multicenter Study on Expressions of Vascular Endothelial Growth Factor, Matrix Metallopeptidase-9 and Tissue Inhibitor of Metalloproteinase-2 in Oral and Maxillofacial Squamous Cell Carcinoma, Iran Red Crescent Med J. 2014 ; 16(3):e13185. doi: 10.5812/ircmj.13185.

Copyright © 2014, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Shakib K, Schrattenholz A, Soskic V. Stem cells in head and neck squamous cell carcinoma. Br J Oral Maxillofac Surg. 2011; 49(7): 503-6[DOI][PubMed]
  • 2. Sterz CM, Kulle C, Dakic B, Makarova G, Bottcher MC, Bette M, et al. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol. 2010; 46(2): 116-22[DOI][PubMed]
  • 3. Liu CJ, Chang KW, Lin SC, Cheng HW. Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol. 2009; 45(10): 920-5[DOI][PubMed]
  • 4. Roderfeld M, Rath T, Lammert F, Dierkes C, Graf J, Roeb E. Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World J Hepatol. 2010; 2(5): 175-9[DOI][PubMed]
  • 5. Patel V, Marsh CA, Dorsam RT, Mikelis CM, Masedunskas A, Amornphimoltham P, et al. Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res. 2011; 71(22): 7103-12[DOI][PubMed]
  • 6. Elahi M, Rakhshan V, Ghasemian NT, Moshref M. Prognostic value of transforming growth factor beta 1 [TGF-beta1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma. Biomarkers. 2012; 17(1): 21-7[DOI][PubMed]
  • 7. Suboj P, Babykutty S, Valiyaparambil Gopi DR, Nair RS, Srinivas P, Gopala S. Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-kappaB. Eur J Pharm Sci. 2012; 45(5): 581-91[DOI][PubMed]
  • 8. Hirano C, Nagata M, Noman AA, Kitamura N, Ohnishi M, Ohyama T, et al. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma. Int J Cancer. 2009; 124(12): 2911-6[DOI][PubMed]
  • 9. Joshua B, Kaplan MJ, Doweck I, Pai R, Weissman IL, Prince ME, et al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck. 2012; 34(1): 42-9[DOI][PubMed]
  • 10. Mohtasham N, Babakoohi S, Shiva A, Shadman A, Kamyab-Hesari K, Shakeri MT, et al. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity. Pathol Res Pract. 2013; 209(2): 110-4[DOI][PubMed]
  • 11. Heo SH, Choi YJ, Ryoo HM, Cho JY. Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis. J Cell Physiol. 2010; 224(3): 734-42[DOI][PubMed]
  • 12. Chetty C, Lakka SS, Bhoopathi P, Rao JS. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer. 2010; 127(5): 1081-95[DOI][PubMed]
  • 13. Kapoor V, Zaharieva MM, Das SN, Berger MR. Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma. Cancer Lett. 2012; 319(1): 39-48[DOI][PubMed]
  • 14. Li M, Wu S, Liu Z, Zhang W, Xu J, Wang Y, et al. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway. Biochem Pharmacol. 2012; 83(9): 1251-60[DOI][PubMed]
  • 15. Gao Q, Tong W, Luria JS, Wang Z, Nussenbaum B, Krebsbach PH. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010; 39(3): 266-71[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments